Free Trial

Daniel Stauder Analyst Performance

Analyst at Citizens Jmp

Daniel Stauder is a stock analyst at Citizens Jmp in the medical sector, covering 4 publicly traded companies. Over the past year, Daniel Stauder has issued 7 stock ratings, including and buy recommendations. While full access to Daniel Stauder's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Daniel Stauder's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
9 Last 1 Years
Buy Recommendations
100.00% 9 Buy Ratings
Companies Covered
4 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy0.0%0 ratings
Buy100.0%9 ratings
Hold0.0%0 ratings
Sell0.0%0 ratings

the majority (100.0%) have been Buy recommendations.

Exchange Coverage

ExchangePercentageCount
NASDAQ
50.0% of companies on NASDAQ
2 companies
NYSEAMERICAN
25.0% of companies on NYSEAMERICAN
1 company
NYSE
25.0% of companies on NYSE
1 company

Daniel Stauder, an analyst at Citizens Jmp, currently covers 4 companies listed on NASDAQ, NYSEAMERICAN and NYSE, with the majority traded on NASDAQ.

Coverage Focus

Sector IconSectorPercentage
Medical
4 companies
100.0%

Daniel Stauder of Citizens Jmp specializes in stock coverage within the Medical sector.

Coverage Industries

IndustryPercentage
MED PRODUCTS
2 companies
50.0%
MED INSTRUMENTS
2 companies
50.0%

Daniel Stauder's Ratings History at Citizens Jmp

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
LeMaitre Vascular, Inc. stock logo
LMAT
LeMaitre Vascular
2/26/2026Boost Price Target$103.63$118.00Market Outperform
AtriCure, Inc. stock logo
ATRC
AtriCure
2/18/2026Lower Price Target$32.52$52.00Market Outperform
Stereotaxis Inc. stock logo
STXS
Stereotaxis
12/16/2025Initiated Coverage$2.32$4.00Market Outperform
Artivion, Inc. stock logo
AORT
Artivion
11/7/2025Boost Price Target$47.54$53.00Market Outperform
Artivion, Inc. stock logo
AORT
Artivion
10/10/2025Boost Price Target$40.32$47.00Market Outperform
Artivion, Inc. stock logo
AORT
Artivion
8/8/2025Boost Price Target$39.09$42.00Market Outperform
Artivion, Inc. stock logo
AORT
Artivion
5/6/2025Reiterated Rating$26.02$33.00Market Outperform
AtriCure, Inc. stock logo
ATRC
AtriCure
4/30/2025Reiterated Rating$29.29$60.00Market Outperform
AtriCure, Inc. stock logo
ATRC
AtriCure
2/10/2025Reiterated Rating$41.29$60.00Market Outperform